Preoperative circulating fibrinogen to albumin ratio in predicting 5-year prognosis of oral cancer radical surgery.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1246, doi. 10.4149/neo_2022_220422N441
- By:
- Publication type:
- Article
Works matching IS 00282685 AND DT 2022 AND VI 69 AND IP 5
Results: 24
1
2
Predictive and prognostic impact of the different features of tumor budding in stage II colorectal cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1237, doi. 10.4149/neo_2022_220525N557
- By:
- Publication type:
- Article
3
Association between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1228, doi. 10.4149/neo_2022_220428N463
- By:
- Publication type:
- Article
4
XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1217, doi. 10.4149/neo_2022_220329N352
- By:
- Publication type:
- Article
5
Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1209, doi. 10.4149/neo_2022_220614N629
- By:
- Publication type:
- Article
6
Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1198, doi. 10.4149/neo_2022_220314N279
- By:
- Publication type:
- Article
7
EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1185, doi. 10.4149/neo_2022_220117N74
- By:
- Publication type:
- Article
8
SNHG9/miR-214-5p/SOX4 feedback loop regulates osteosarcoma progression.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1175, doi. 10.4149/neo_2022_220228N218
- By:
- Publication type:
- Article
9
NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1165, doi. 10.4149/neo_2022_211102N1559
- By:
- Publication type:
- Article
10
DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1154, doi. 10.4149/neo_2022_220316N289
- By:
- Publication type:
- Article
11
lncRNA PSMB8-AS1 promotes colorectal cancer progression through sponging miR-1299 to upregulate ADAMTS5.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1138, doi. 10.4149/neo_2022_220111N42
- By:
- Publication type:
- Article
12
Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1129, doi. 10.4149/neo_2022_220414N410
- By:
- Publication type:
- Article
13
Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1119, doi. 10.4149/neo_2022_220624N661
- By:
- Publication type:
- Article
14
SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1108, doi. 10.4149/neo_2022_220415N416
- By:
- Publication type:
- Article
15
SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1101, doi. 10.4149/neo_2022_220324N333
- By:
- Publication type:
- Article
16
Correlation between metastasis-associated gene 1 expression and tumorassociated macrophages in non-small cell lung cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1092, doi. 10.4149/neo_2022_220615N637
- By:
- Publication type:
- Article
17
hsa_circ_0067514 suppresses gastric cancer progression and glycolysis via miR-654-3p/LATS2 axis.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1079, doi. 10.4149/neo_2022_220225N209
- By:
- Publication type:
- Article
18
BRAF inhibition promotes ER stress-mediated cell death in uveal melanoma.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1070, doi. 10.4149/neo_2022_220428N462
- By:
- Publication type:
- Article
19
HSPA5 repressed ferroptosis to promote colorectal cancer development by maintaining GPX4 stability.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1054, doi. 10.4149/neo_2022_220331N363
- By:
- Publication type:
- Article
20
Exosomes from M2 macrophages promoted glycolysis in FaDu cells by inhibiting PDLIM2 expression to stabilize PFKL.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1041, doi. 10.4149/neo_2022_220426N455
- By:
- Publication type:
- Article
21
Sodium butyrate inhibits oral squamous cell carcinoma proliferation and invasion by regulating the HDAC1/HSPB7 axis.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1029, doi. 10.4149/neo_2022_220311N270
- By:
- Publication type:
- Article
22
Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1019, doi. 10.4149/neo_2022_220611N619
- By:
- Publication type:
- Article
23
CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1008, doi. 10.4149/neo_2022_220504N477
- By:
- Publication type:
- Article
24
Exploring novel systemic therapies for pancreatic cancer: a review of emerging anti-PD-1/PD-L1 combination therapy.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 995, doi. 10.4149/neo_2022_220306N246
- By:
- Publication type:
- Article